Job Trends
Labor Market Reports
BioSpace’s 2026 U.S. Life Sciences Employment Outlook examines the state of the biopharma workforce amid ongoing funding pressure, elevated layoffs and cautious hiring sentiment, while highlighting early signals of stabilization and cautious optimism for the year ahead.
BioSpace’s 2025 Q4 U.S. Life Sciences Job Market update highlights early signs of stabilization in biopharma hiring, with modest gains in job postings, slowing layoffs, and cautiously improving sentiment heading into 2026.
BioSpace’s Q3 2025 U.S. Life Sciences Job Market Report reveals a turbulent quarter for biopharma hiring, with record declines in job postings, rising layoffs, and cautious employer sentiment shaping the industry’s employment landscape.
Now Hiring
Looking for an IT job? From data engineer to information security, check out the BioSpace list of 10 companies hiring life sciences professionals like you.
More biopharma organizations were actively recruiting at the end of 2025 than 2024, based on the new BioSpace employment outlook report. Areas in demand this year include research and development and clinical. Organizations are also prioritizing artificial intelligence hires.
Looking for a research and development job? Check out the BioSpace list of 12 companies hiring life sciences professionals like you.
Career Advice
With leaner teams and tighter budgets, senior leaders can face tremendous strain as they juggle increased workloads and leadership responsibilities. In this column, Kaye/Bassman’s Michael Pietrack discusses how pressure builds and what can ease it.
THE LATEST
Corporate culture is interesting because it affects almost every aspect of a business.
“We are excited about entering into an agreement to acquire The Medicines Company as inclisiran is a potentially transformational medicine that reimagines the treatment of atherosclerotic heart disease and familial hypercholesterolemia,” said Vas Narasimhan, chief executive officer of Novartis.
The company has doubled its headcount to about 60 employees and doubled its square-footage in the city with the 26,000 square-foot facility.
As usual, it was a busy week for clinical trial updates. Here’s a look.
Accumen has acquired three companies this year, allowing it to generate significant additional value for hospitals and health system, commercial laboratory, and health plan clients
The capital investment was driven by increasing demand for Lilly’s current medicines, as well as future medicines that will come from its pipeline, the company said.
Invisian Medical awarded Innovative Technology group purchasing contract by Vizient to offer patent-pending Minne Ties fixation technology for jaw fractures and other jaw-related surgeries to its members
With Thanksgiving just around the corner, now is a good time to reflect on things you’re thankful for.
The research will focus on nanotechnology based CBD- products for the treatment of psoriasis and other diseases
We interviewed three women with thriving life sciences careers to dive deeper into what women prioritize in an employer.